Medical devices for the treatment of obesity

[1]  J. Cho,et al.  Comparison between an electronic version of the foot and ankle outcome score and the standard paper version , 2019, Medicine.

[2]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[3]  S. Msika,et al.  Impact of Intragastric Balloon Before Laparoscopic Gastric Bypass on Patients with Super Obesity: a Randomized Multicenter Study , 2017, Obesity Surgery.

[4]  V. Shayani,et al.  Intragastric balloon as an adjunct to lifestyle intervention: a randomized controlled trial , 2017, International Journal of Obesity.

[5]  J. Holst,et al.  The impact of EndoBarrier gastrointestinal liner in obese patients with normal glucose tolerance and in patients with type 2 diabetes , 2017, Diabetes, obesity & metabolism.

[6]  Joseph P. Glaser,et al.  Percutaneous Gastrostomy Device for the Treatment of Class II and Class III Obesity: Results of a Randomized Controlled Trial , 2016, The American Journal of Gastroenterology.

[7]  M. Marcus,et al.  Effect of Wearable Technology Combined With a Lifestyle Intervention on Long-term Weight Loss: The IDEA Randomized Clinical Trial. , 2016, JAMA.

[8]  M. Anselmino,et al.  Closed-loop gastric electrical stimulation versus laparoscopic adjustable gastric band for the treatment of obesity: a randomized 12-month multicenter study , 2016, International Journal of Obesity.

[9]  K. Haua‐Navarro,et al.  Overweight and Obesity , 2012, Introduction to Nutrition and Metabolism.

[10]  C. Thompson,et al.  Endoscopic Duodenal Mucosal Resurfacing for the Treatment of Type 2 Diabetes: 6-Month Interim Analysis From the First-in-Human Proof-of-Concept Study , 2016, Diabetes Care.

[11]  C. Apovian,et al.  Two-Year Outcomes of Vagal Nerve Blocking (vBloc) for the Treatment of Obesity in the ReCharge Trial , 2016, Obesity Surgery.

[12]  J. Dixon,et al.  A prospective, international, multi-center, non-randomized, open label study (HERO) of health outcomes and the rates of explants and reoperations after 5 years of treatment with laparoscopic adjustable gastric banding , 2016 .

[13]  Kathryn L. Rock,et al.  Trends in bariatric surgery from 2008 to 2012. , 2016, American journal of surgery.

[14]  K. Dumon,et al.  Endoscopic treatments of obesity: a comprehensive review. , 2016, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[15]  J. Dixon,et al.  An investigation of the neural mechanisms underlying the efficacy of the adjustable gastric band. , 2016, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[16]  I. Issa,et al.  Acute pancreatitis caused by intragastric balloon: A case report. , 2016, Obesity research & clinical practice.

[17]  H. Lebovitz.  Interventional treatment of obesity and diabetes: An interim report on gastric electrical stimulation , 2016, Reviews in Endocrine and Metabolic Disorders.

[18]  L. de las Fuentes,et al.  Effects of Moderate and Subsequent Progressive Weight Loss on Metabolic Function and Adipose Tissue Biology in Humans with Obesity. , 2016, Cell metabolism.

[19]  J. Kuk,et al.  Interest, views and perceived barriers to bariatric surgery in patients with morbid obesity , 2016, Clinical obesity.

[20]  F. K. Knop,et al.  Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: a systematic review and meta‐analysis , 2016, Diabetes, obesity & metabolism.

[21]  R. Chuttani,et al.  Elipse™, a Procedureless Gastric Balloon for Weight Loss: a Proof-of-Concept Pilot Study , 2016, Obesity Surgery.

[22]  J. Dixon,et al.  LAP-BAND for BMI 30–40: 5-year health outcomes from the multicenter pivotal study , 2016, International Journal of Obesity.

[23]  J. Dargent.  Novel Endoscopic Management of Obesity , 2016, Clinical endoscopy.

[24]  J. Dixon,et al.  Neuroendocrine adaptations to bariatric surgery , 2015, Molecular and Cellular Endocrinology.

[25]  E. Aarts,et al.  Safety experience with the duodenal-jejunal bypass liner: an endoscopic treatment for diabetes and obesity. , 2015, Gastrointestinal endoscopy.

[26]  M. Leon,et al.  Endovascular Bariatrics: First in Humans Study of Gastric Artery Embolization for Weight Loss. , 2015, JACC. Cardiovascular interventions.

[27]  Nitin Kumar.  Endoscopic therapy for weight loss: Gastroplasty, duodenal sleeves, intragastric balloons, and aspiration. , 2015, World journal of gastrointestinal endoscopy.

[28]  C. Apovian,et al.  Sustained Weight Loss with Vagal Nerve Blockade but Not with Sham: 18-Month Results of the ReCharge Trial , 2015, Journal of obesity.

[29]  C. Apovian,et al.  Challenging obesity: Patient, provider, and expert perspectives on the roles of available and emerging nonsurgical therapies , 2015, Obesity.

[30]  S. Ikramuddin,et al.  The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity. , 2015, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[31]  H. Lebovitz,et al.  Gastric electrical stimulation treatment of type 2 diabetes: effects of implantation versus meal-mediated stimulation. A randomized blinded cross-over trial , 2015, Physiological reports.

[32]  H. Lebovitz,et al.  Treatment of Patients with Obese Type 2 Diabetes with Tantalus-DIAMOND® Gastric Electrical Stimulation: Normal Triglycerides Predict Durable Effects for at Least 3 Years , 2015, Hormone and Metabolic Research.

[33]  N. Scopinaro,et al.  Bariatric Surgery Worldwide 2013 , 2015, Obesity Surgery.

[34]  T. Horbach,et al.  abiliti® Closed-Loop Gastric Electrical Stimulation System for Treatment of Obesity: Clinical Results with a 27-Month Follow-Up , 2015, Obesity Surgery.

[35]  J. Stevens,et al.  US adults recommended for weight reduction by 1998 and 2013 obesity guidelines, NHANES 2007‐2012 , 2015, Obesity.

[36]  C. Buchpiguel,et al.  Effects of Duodenal-Jejunal Bypass Liner (EndoBarrier®) on Gastric Emptying in Obese and Type 2 Diabetic Patients , 2015, Obesity Surgery.

[37]  M. Talamini,et al.  One-year human experience with a novel endoluminal, endoscopic gastric bypass sleeve for morbid obesity , 2015, Surgical Endoscopy.

[38]  C. Apovian,et al.  Pharmacological management of obesity: an endocrine Society clinical practice guideline. , 2015, The Journal of clinical endocrinology and metabolism.

[39]  J. Greve,et al.  The Effect of the Endoscopic Duodenal-Jejunal Bypass Liner on Obesity and Type 2 Diabetes Mellitus, a Multicenter Randomized Controlled Trial , 2014, Annals of surgery.

[40]  M. Serrano,et al.  Early Experience with Customized, Meal-Triggered Gastric Electrical Stimulation in Obese Patients , 2014, Obesity Surgery.

[41]  H. Forssell,et al.  A novel endoscopic weight loss therapy using gastric aspiration: results after 6 months , 2014, Endoscopy.

[42]  James Toouli,et al.  Effect of reversible intermittent intra-abdominal vagal nerve blockade on morbid obesity: the ReCharge randomized clinical trial. , 2014, JAMA.

[43]  F. Greenway,et al.  Weight loss and improved quality of life with a nonsurgical endoscopic treatment for obesity: clinical results from a 3- and 6-month study. , 2014, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[44]  F. Hu,et al.  2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. , 2014, Journal of the American College of Cardiology.

[45]  J. Donovan,et al.  The By-Band study: gastric bypass or adjustable gastric band surgery to treat morbid obesity: study protocol for a multi-centre randomised controlled trial with an internal pilot phase , 2014, Trials.

[46]  M. Huic,et al.  The Duodenal–Jejunal Bypass Liner for the Treatment of Type 2 Diabetes Mellitus and/or Obesity: a Systematic Review , 2014, Obesity Surgery.

[47]  D. Mullady,et al.  Aspiration therapy leads to weight loss in obese subjects: a pilot study. , 2013, Gastroenterology.

[48]  Janusz Wnek,et al.  2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults , 2013, Circulation.

[49]  S. Whitcup,et al.  LAP‐BAND® for Lower BMI: 2‐Year Results from the Multicenter Pivotal Study , 2013, Obesity.

[50]  E. Mathus-Vliegen,et al.  Fasting and Meal-Induced CCK and PP Secretion Following Intragastric Balloon Treatment for Obesity , 2013, Obesity Surgery.

[51]  J. Greve,et al.  Endoscopic Duodenal–Jejunal Bypass Liner Rapidly Improves Type 2 Diabetes , 2013, Obesity Surgery.

[52]  S. Roman,et al.  Swallowable Obalon® Gastric Balloons as an Aid for Weight Loss: A Pilot Feasibility Study , 2013, Obesity Surgery.

[53]  H. Lebovitz,et al.  Fasting plasma triglycerides predict the glycaemic response to treatment of Type 2 diabetes by gastric electrical stimulation. A novel lipotoxicity paradigm , 2013, Diabetic medicine : a journal of the British Diabetic Association.

[54]  Herbert Lerner,et al.  Benefit-risk paradigm for clinical trial design of obesity devices: FDA proposal , 2013, Surgical Endoscopy.

[55]  M. Talamini.  Benefit-risk paradigm for clinical trial design of obesity devices: FDA proposal , 2013, Surgical Endoscopy.

[56]  Margaret Anderson,et al.  Long-Term Outcomes After Bariatric Surgery: Fifteen-Year Follow-Up of Adjustable Gastric Banding and a Systematic Review of the Bariatric Surgical Literature , 2013, Annals of surgery.

[57]  J. Dixon,et al.  Laparoscopic Adjustable Gastric Banding and Other Devices for the Management of Obesity , 2012, Circulation.

[58]  J. Cook,et al.  Results of a randomized controlled trial of mental illness self-management using Wellness Recovery Action Planning. , 2012, Schizophrenia bulletin.

[59]  David M. Nestler,et al.  The Chest Pain Choice Decision Aid: A Randomized Trial , 2012, Circulation. Cardiovascular quality and outcomes.

[60]  Asge Asmbs Task Force on Endoscopic Bariatric Therapy.  A pathway to endoscopic bariatric therapies. , 2011, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[61]  A. Shulkes,et al.  Long-term persistence of hormonal adaptations to weight loss. , 2011, The New England journal of medicine.

[62]  J. Dixon,et al.  Pancreatic Polypeptide Meal Response May Predict Gastric Band-Induced Weight Loss , 2011, Obesity surgery.

[63]  J. Clarke,et al.  What is a systematic review? , 2011, Evidence Based Nursing.

[64]  Jeffrey Brooks,et al.  Adjustable Intragastric Balloons: A 12-Month Pilot Trial in Endoscopic Weight Loss Management , 2011, Obesity surgery.

[65]  P. O’Brien,et al.  Systematic Review of Erosion after Laparoscopic Adjustable Gastric Banding , 2011, Obesity surgery.

[66]  M. Talamini,et al.  Human experience with an endoluminal, endoscopic, gastrojejunal bypass sleeve , 2011, Surgical Endoscopy.

[67]  C. Gostout,et al.  791 Adjustable Intragastric Balloons: A 12 Month Pilot Trial in Endoscopic Weight Loss Management , 2011 .

[68]  G. Hebbard,et al.  Changes in Satiety, Supra- and Infraband Transit, and Gastric Emptying Following Laparoscopic Adjustable Gastric Banding: A Prospective Follow-up Study , 2011, Obesity surgery.

[69]  H. Glick,et al.  Direct medical cost of overweight and obesity in the USA: a quantitative systematic review , 2011, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[70]  C. Meyerhoefer,et al.  The Medical Care Costs of Obesity: an Instrumental Variables Approach , 2010, Journal of health economics.

[71]  V. Pate,et al.  Baseline data from American Society for Metabolic and Bariatric Surgery-designated Bariatric Surgery Centers of Excellence using the Bariatric Outcomes Longitudinal Database. , 2010, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[72]  Christine A Pellegrini,et al.  The Comparison of a Technology‐Based System and an In‐Person Behavioral Weight Loss Intervention , 2010, Obesity.

[73]  E. Pena,et al.  Efficacy, Safety, and Tolerance of Two Types of Intragastric Balloons Placed in Obese Subjects: A Double-Blind Comparative Study , 2010, Obesity surgery.

[74]  J. Shaw,et al.  The cost of overweight and obesity in Australia , 2010, The Medical journal of Australia.

[75]  S. Skinner,et al.  Laparoscopic adjustable gastric banding in severely obese adolescents: a randomized trial. , 2010, JAMA.

[76]  M. A. Chapman,et al.  Laparoscopic Gastric Banding Is Safe in Outpatient Surgical Centers , 2010, Obesity surgery.

[77]  E. Finkelstein,et al.  Annual medical spending attributable to obesity: payer-and service-specific estimates. , 2009, Health affairs.

[78]  S. Bhoyrul,et al.  Safety and effectiveness of Realize adjustable gastric band: 3-year prospective study in the United States. , 2009, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[79]  B. Wolfe,et al.  Perioperative safety in the longitudinal assessment of bariatric surgery. , 2009, The New England journal of medicine.

[80]  C. Apovian,et al.  Best Practice Updates for Multidisciplinary Care in Weight Loss Surgery , 2009, Obesity.

[81]  A. Dabrowski,et al.  The effect of intragastric balloon on plasma ghrelin, leptin, and adiponectin levels in patients with morbid obesity. , 2009, The Journal of clinical endocrinology and metabolism.

[82]  Wei-Jei Lee,et al.  Serum C-Reactive Protein and White Blood Cell Count in Morbidly Obese Surgical Patients , 2009, Obesity surgery.

[83]  M. Jensen,et al.  Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. , 2009, The American journal of medicine.

[84]  S. Göttig,et al.  Preoperative Weight Reduction Using the Intragastric Balloon , 2009, Obesity Facts.

[85]  M. Moodie,et al.  Cost-Effectiveness of Surgically Induced Weight Loss for the Management of Type 2 Diabetes: Modeled Lifetime Analysis , 2009, Diabetes Care.

[86]  D. Gallagher,et al.  Long-term persistence of adaptive thermogenesis in subjects who have maintained a reduced body weight. , 2008, The American journal of clinical nutrition.

[87]  Ali Benmousa,et al.  Acute Pancreatitis Complicating Intragastric Balloon Insertion , 2008, Case Reports in Gastroenterology.

[88]  R. Lancaster,et al.  Bands and bypasses: 30-day morbidity and mortality of bariatric surgical procedures as assessed by prospective, multi-center, risk-adjusted ACS-NSQIP data , 2008, Surgical Endoscopy.

[89]  H. Buchwald,et al.  A study on the economic impact of bariatric surgery. , 2008, The American journal of managed care.

[90]  J. Dumonceau,et al.  Evidence-based Review of the Bioenterics Intragastric Balloon for Weight Loss , 2008, Obesity surgery.

[91]  J Toouli,et al.  Intra-abdominal vagal blocking (VBLOC therapy): clinical results with a new implantable medical device. , 2008, Surgery.

[92]  C. Martínez-Cervell,et al.  Safety and Effectiveness of the Intragastric Balloon for Obesity. A Meta-Analysis , 2008, Obesity surgery.

[93]  R. Rosenthal,et al.  Perceived barriers to bariatric surgery among morbidly obese patients. , 2008, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[94]  B. Chand,et al.  Endoluminal procedures for bariatric patients: expectations among bariatric surgeons. , 2008, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[95]  J. H. Ahroni,et al.  Laparoscopic adjustable gastric banding in an ambulatory surgery center. , 2008, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[96]  H. Berthoud.  Vagal and hormonal gut–brain communication: from satiation to satisfaction , 2008, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[97]  E. Finkelstein,et al.  Indirect costs of obesity: a review of the current literature , 2008, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[98]  Margaret Anderson,et al.  Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. , 2008, JAMA.

[99]  D. English,et al.  Substantial Intentional Weight Loss and Mortality in the Severely Obese , 2007, Annals of surgery.

[100]  H. Buchwald,et al.  Trends in mortality in bariatric surgery: a systematic review and meta-analysis. , 2007, Surgery.

[101]  M. Petroni,et al.  Comparative long-term mortality after laparoscopic adjustable gastric banding versus nonsurgical controls. , 2007, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[102]  R. Astorga,et al.  Intragastric Balloon-Induced Satiety is Not Mediated by Modification in Fasting or Postprandial Plasma Ghrelin Levels in Morbid Obesity , 2007, Obesity surgery.

[103]  Deborah F Tate,et al.  The Efficacy of a Technology‐based System in a Short‐term Behavioral Weight Loss Intervention , 2007, Obesity.

[104]  P. Parrilla,et al.  Intragastric Balloon Reduces Liver Volume in Super-Obese Patients, Facilitating Subsequent Laparoscopic Gastric Bypass , 2007, Obesity surgery.

[105]  J. Marescaux,et al.  The Mechanism of Diabetes Control After Gastrointestinal Bypass Surgery Reveals a Role of the Proximal Small Intestine in the Pathophysiology of Type 2 Diabetes , 2006, Annals of surgery.

[106]  S. Skinner,et al.  Treatment of Mild to Moderate Obesity with Laparoscopic Adjustable Gastric Banding or an Intensive Medical Program , 2006, Annals of Internal Medicine.

[107]  F. Pattou,et al.  Intragastric Balloon for Preoperative Weight Reduction in Candidates for Laparoscopic Gastric Bypass with Massive Obesity , 2006, Obesity surgery.

[108]  M. Parikh,et al.  Objective comparison of complications resulting from laparoscopic bariatric procedures. , 2006, Journal of the American College of Surgeons.

[109]  N. Basso,et al.  BioEnterics Intragastric Balloon: The Italian Experience with 2,515 Patients , 2005, Obesity surgery.

[110]  S. Roman,et al.  Effects of Intragastric Balloon on Gastric Emptying and Plasma Ghrelin Levels in Non-morbid Obese Patients , 2005, Obesity surgery.

[111]  J. Dixon,et al.  Laparoscopic adjustable gastric banding induces prolonged satiety: a randomized blind crossover study. , 2005, The Journal of clinical endocrinology and metabolism.

[112]  P. Sallet,et al.  Brazilian Multicenter Study of the Intragastric Balloon , 2004, Obesity surgery.

[113]  R. Ritter,et al.  Gastrointestinal mechanisms of satiation for food , 2004, Physiology & Behavior.

[114]  S. Roman,et al.  Intragastric Balloon for "Non-Morbid" Obesity: A Retrospective Evaluation of Tolerance and Efficacy , 2004, Obesity surgery.

[115]  G. Maddern,et al.  Laparoscopic adjustable gastric banding in the treatment of obesity: a systematic literature review. , 2004, Surgery.

[116]  J. Dixon,et al.  Changes in comorbidities and improvements in quality of life after LAP-BAND placement. , 2002, American journal of surgery.

[117]  R. van Hee,et al.  Weight Reduction by Means of Intragastric Device: Experience with the Bioenterics Intragastric Balloon , 2001, Obesity surgery.

[118]  C. Baird.  The pilot study. , 2000, Orthopedic nursing.

[119]  G. D. De Palma,et al.  Preliminary Endoscopic Technical Report of a New Silicone Intragastric Balloon in the Treatment of Morbid Obesity , 1999, Obesity surgery.

[120]  Tony Travers,et al.  A Comprehensive Review , 1998 .

[121]  M. Belachew,et al.  Laparoscopic Placement of Adjustable Silicone Gastric Band in the Treatment of Morbid Obesity: How to Do It , 1995, Obesity surgery.

[122]  F. M. Kramer,et al.  Limited weight losses with a gastric balloon. , 1989, Archives of internal medicine.

[123]  R. Kozarek,et al.  Obesity and the gastric balloon: a comprehensive workshop. Tarpon Springs, Florida, March 19-21, 1987. , 1987, Gastrointestinal endoscopy.

[124]  Henrik Harboe,et al.  INTRAGASTRIC BALLOON AS AN ARTIFICIAL BEZOAR FOR TREATMENT OF OBESITY , 1982, The Lancet.

[125]  T. D. Gamson.  A Comprehensive Workshop. , 1979 .

[126]  高井 俊夫.  奇形・脳性麻痺の起因に関するprospective follow up studyについて , 1966 .

[127]  M. CORREA ITURRASPE.  [Surgical treatment of obesity]. , 1952, Revista de la Asociacion Medica Argentina.

[128]  Jerry Sullivan,et al.  Review of current literature , 1931, International Urogynecology Journal.

[129]  D. Werring,et al.  Randomized Controlled Trial , 2020, Encyclopedia of Behavioral Medicine.

[130]  G. Formisano,et al.  Bariatric Surgery Worldwide , 2017 .

[131]  J. Vendrell,et al.  Endobarrier® in Grade I Obese Patients with Long-Standing Type 2 Diabetes: Role of Gastrointestinal Hormones in Glucose Metabolism , 2016, Obesity Surgery.

[132]  G. de Lartigue,et al.  Role of the vagus nerve in the development and treatment of diet‐induced obesity , 2016, The Journal of physiology.

[133]  N. Vilarrasa.  EndoBarrier® in Grade I Obese Patients with Long-Standing Type 2 Diabetes: Role of Gastrointestinal Hormones in Glucose Metabolism , 2016, Obesity Surgery.

[134]  T. Baron,et al.  Endoscopic ultrasound-guided drainage and necrosectomy of walled-off pancreatic necrosis using a metal stent with an electrocautery-enhanced delivery system and hydrogen peroxide , 2015, Endoscopy.

[135]  E. Mathus-Vliegen,et al.  Fasting and Meal-Suppressed Ghrelin Levels Before and After Intragastric Balloons and Balloon-Induced Weight Loss , 2013, Obesity Surgery.

[136]  M. Nutt,et al.  Are intra-gastric adjustable balloon system safe? A case series. , 2013, International journal of surgery case reports.

[137]  David Hamilton,et al.  Blood Glucose Prediction Using Artificial Neural Networks Trained with the AIDA Diabetes Simulator: A Proof-of-Concept Pilot Study , 2011, J. Electr. Comput. Eng..

[138]  F. Greenway,et al.  An Endocrine Society Clinical Practice Guideline Endocrine and Nutritional Management of the Post-Bariatric Surgery Patient: , 2010 .

[139]  Marc Bessler,et al.  Implantable gastric stimulation for the treatment of clinically severe obesity: results of the SHAPE trial. , 2009, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[140]  A. Al-Momen,et al.  Intragastric Balloon for Obesity: A Retrospective Evaluation of Tolerance and Efficacy , 2005, Obesity surgery.

[141]  N. Basso,et al.  BioEnterics® Intragastric Balloon (BIB®): a short-term, double-blind, randomised, controlled, crossover study on weight reduction in morbidly obese patients , 2005, International Journal of Obesity.

[142]  Teresa Foo,et al.  : SYSTEMATIC LITERATURE REVIEW , 2004 .

[143]  D. C. Henckel,et al.  Case report. , 1995, Journal.

[144]  J. Kral,et al.  Surgical treatment of obesity. , 1989, The Medical clinics of North America.

[145]  J. Kral,et al.  Truncal vagotomy in morbid obesity. , 1981, International journal of obesity.

[146]  J. Knox,et al.  Teratogenic efect of anticonvulsants. , 1973, Lancet.